female PD patient complicated with dopamine-induced FOG, which was identified during levodopa challenge test. Her symptoms were alleviated after adjusting the medication.
Case report: Levodopa challenge test is i... - Cure Parkinson's
Case report: Levodopa challenge test is important in identifying dopamine-induced freezing of gait in patient with Parkinson’s disease
Written by
Farooqji
To view profiles and participate in discussions please or .
Read more about...
2 Replies
•
The levodopa induced freezing of gait (FOG) is definitely one of my most challenging and unpleasant symptoms. Sadly, my PD is not benign and I have always suffered from dyskinesia. So, adjusting my meds is not an option for me, which is why I’m having DBS which I’m hoping will allow me to reduce my meds.
Hi, freezing is my biggest issue too. I have tried alot of diffrent things: med adjustments, excercise, cryothreapy, infared threapy, e stim, nothing seeems to help. My MD SAID DBS doesn't help with these symptoms...I also purchased: electric scooter, w/c, crutches, u-step, rollator walker, again nothing helps me.
Not what you're looking for?
You may also like...
Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson’s disease
https://www.nature.com/articles/s41467-019-08294-y
A Computational Model of Levodopa-Induced Toxicity in Substantia Nigra Pars Compacta in Parkinson's Disease
Can the technical people explain the significance of this article:...
Levodopa-Induced Euphoria and Addictions in Parkinson’s. It's of concern for people with neuropsychiatric fluctuations between ON and OFF.
I'm referencing a 2017 research article.
Some people have more significant neuropsychiatric...
Long-Term Satisfaction and Patient-Centered Outcomes of Deep Brain Stimulation in Parkinson’s Disease
Long-Term Satisfaction and Patient-Centered Outcomes of Deep Brain Stimulation in Parkinson’s...
Annovis Bio Announces First Patient Dosed in Phase 3 Trial in Patients with Early Parkinson’s Disease
Annovis Bio Announces First Patient Dosed in Phase 3 Trial in Patients with Early Parkinson’s...